← Open Payments lookup

SOO KANG: Open Payments

NPI 1356983670 · FOLSOM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,322 in 41 payments from 12 companies in 2025. Trend: 2023 $1,554 · 2024 $415 · 2025 $1,322

Food & beverage: $1,322
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.12$326
Otsuka America Pharmaceutical, Inc.5$240
Janssen Pharmaceuticals, Inc7$139
Axsome Therapeutics, Inc.2$138
Vanda Pharmaceuticals Inc.3$135
E.R. Squibb & Sons, L.L.C.1$122
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$65
Supernus Pharmaceuticals, Inc.3$57
Bausch Health US, LLC2$33
Teva Pharmaceuticals USA, Inc.1$29

Products named: INGREZZA, REXULTI, Auvelity, COBENFY, FANAPT, SPRAVATO, CAPLYTA, Qelbree.

Industry payments across CA — which companies pay providers there.